Alcohol and iron

Seminars in Liver Disease

Volumn 24, Issue 3, 2004, Pages 317-325

  Tavill, Anthony S ^a   Qadri, Asif M ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

Alcohol and iron; Apoptosis; Fibrogenesis; Hemochromatosis; Iron overload; Lipid peroxidation; Necrosis; Oxidative stress

Indexed keywords

ALCOHOL; IRON;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; CELL DAMAGE; FIBROGENESIS; HEMOCHROMATOSIS; HUMAN; IRON BALANCE; IRON OVERLOAD; IRON STORAGE; LIVER TOXICITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

ALCOHOL DRINKING; APOPTOSIS; HEPATOCYTES; HUMANS; IRON; LIVER CIRRHOSIS; LIVER DISEASES, ALCOHOLIC; NECROSIS; OXIDATIVE STRESS;

EID: 4444287777     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-832943     Document Type: Review

References (90)

1. Britton RS. Metal-induced hepatoxicity. Semin Liver Dis 1996;16:3-12
2. Niederau C, Fischer R, Purschel A, et al. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107-1119
3. Bacon BR, Britton RS. The pathology of hepatic iron overload: A free radical-mediated process? Hepatology 1990; 11:127-137
4. Pietrangelo A. Metals, oxidative stress, and hepatic fibrogenesis. Semin Liver Dis 1996;16:13-30
5. Pietrangelo A. Mechanisms of liver injury and fibrosis due to iron and copper. American Association for the Study of Liver Diseases (AASLD) Review Course; October 2003:53-58
6. Bacon BR, Tavill AS, Brittenham GM, et al. Hepatic lipid peroxidation in vivo in rats with chronic iron overload. J Clin Invest 1983;71:429-439
7. Pietrangelo A, Gualdi R, Casalgrandi G, et al. Enhanced hepatic collagen type I mRNA expression into fat-storing cells in a rodent model of hemochromatosis. Hepatology 1994; 19:714-721
8. Pietrangelo A, Gualdi R, Casalgrandi G, et al. Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents. J Clin Invest 1995;95:1824-1831
9. Seymour CA, Peters TJ. Organelle pathology in primary and secondary haemochromatosis with special reference to lysosomal changes. Br J Haematol 1978;40:239-253
10. Selden C, Owen M, Hopkins JMP, et al. Studies on the concentration and intracellular localization of iron proteins in liver biopsy specimens from patients with iron overload with special reference to their role in lysosomal disruption. Br J Haematol 1980;44:593-603
11. O'Connell MJ, Ward RJ, Baum H, Peters TJ. The role of iron in ferritin and haemosiderin-mediated lipid peroxidation in lysosomes. Biochem J 1985;229:135-139
12. Hultcrantz R, Ahlberg J, Glaumann H. Isolation of two lysosomal populations from iron-overload rat liver with different iron concentration and proteolytic activity. Virchows Arch [B] 1984;47:55-65
13. Myers BM, Prendergast FG, Holman R, et al. Alterations in structure, physicochemical properties, and pH of hepatocyte lysosomes in experimental iron overload. J Clin Invest 1991; 88:1207-1215
14. Seymour CA, Peters TJ. Organelle pathology in primary and secondary haemochromatosis with special reference to lysosomal changes. Br J Haematol 1978;40:239-253
15. Britton RS, Ramm GA, Olynyk J, et al. Pathophysiology of iron toxicity. Adv Exp Med Biol 1994;356:239-253
16. Park CH, Bacon BR, Brittenham GM, Tavill AS. Pathology of dietary carbonyl iron overload in rats. Lab Invest 1987; 57:555-563
17. Rauen U, Petrat F, Sustmann R, de Groon H. Iron-induced mitochondrial permeability transition in cultured hepatocytes. J Hepatol 2004;40:607-615
18. LeMasters JL. Rusty notions of cell injury. J Hepatol 2004; 40:696-698
19. Tavill AS, Bacon BR. Hemochromatosis: how much iron is too much? Hepatology 1986;6:142-145
20. Summers KM, Halliday JW, Powell LW. Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index. Hepatology 1990;12:20-25
21. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986;6:24-29
22. Sallie R, Reed WD, Shilkin KB. Confirmation of the efficacy of the hepatic iron index in differentiating genetic haemochromatosis from alcoholic liver disease complicated by alcoholic haemosiderosis. Gut 1991;32:207-210
23. Beaton M, Guyader D, Deugnier Y, et al. Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis. Hepatology 2002;36:673-678
24. Morrison ED, Brandhagen DJ, Phatak PD, et al. Serum ferritin levels predict advanced hepatic fibrosis among U. S. patients with phenotypic hemochromatosis. Ann Intern Med 2003;138:627-633
25. Pietrangelo A, Rocchi E, Schiaffonoti L, et al. Liver gene expression during chronic dietary iron overload in rats. Hepatology 1990;11:798-804
26. Pietrangelo A, Borella F, Casalgrandi G, et al. Antioxidant activity of silybin in vivo during long-term iron overload in rats. Gastroenterology 1995;109:1941-1949
27. Houglum K, Grant AR, Crawford DHG, et al. Excess iron induces hepatic oxidative stress and transforming growth factor B1 in genetic hemochromatosis. Hepatology 1997;26:605-610
28. Parola M, Robino G, Dianzani MU. 4-hydroxy-2, 3-alkenals as molecular mediators of oxidative stress in the pathogenesis of liver fibrosis. Int J Mol Med 1999;4:425-432
29. Zhou XY, Tomatsu S, Fleming RE, et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci USA 1998;95:2492-2497
30. Bell H, Skinningsrud A, Raknerud N, Try K. Serum ferritin and transferrin saturation in patients with chronic alcoholic and non-alcoholic liver disease. J Intern Med 1994;236:315-322
31. Sabesin SM, Thomas LB. Parenchymal siderosis in patients with preexisting portal cirrhosis. A pathologic entity simulating idiopathic and transfusional hemochromatosis. Gastroenterology 1964;46:477-485
32. Powell LW. Normal human iron storage and its relation to ethanol consumption. Australas Ann Med 1966;15:110-115
33. Lundvall O, Weinfeld A, Lundin P. Iron stores in alcohol abusers. Acta Med Scand 1969;185:259-269
34. Jacobovits A, Morgan MY, Sherlock S. Hepatic siderosis in alcoholics. Dig Dis Sci 1979;24:305-310
35. MacDonald RA. Primary hemochromatosis: inherited or acquired? Prog Hematol 1966;5:324-353
36. Simon M, Bourel M, Genetet B, Fauchet R. Idiopathic hemochromatosis. Demonstration of recessive transmission and early detection by family HLA typing. N Engl J Med 1977;297:1017-1021
37. Simon M, Bourel M, Genetet B, et al. Idiopathic hemochromatosis and iron overload in alcoholic liver disease: differentiation by HLA phenotype. Gastroenterology 1977;73:655-658
38. Simon M, Alexandre JL, Bourel M, et al. Heredity of idiopathic haemochromatosis: a study of 106 families. Clin Genet 1977;11:327-341
39. Simon M, Bourel M, Genetet B, Fauchet R. Idiopathic haemochromatosis: demonstration of recessive transmission and early detection by family HLA typing. N Engl J Med 1977;297:1017-1022
40. Finch SC, Finch CA. Idiopathic hemochromatosis, an iron storage disease. A. Iron metabolism in hemochromatosis. Medicine 1955;34:381-430
41. Milder MS, Cook JD, Stray S, Finch CA. Idiopathic hemochromatosis, an interim report. Medicine (Baltimore) 1980;59:34-49
42. Powell LW, Iron storage in relatives of patients with haemochromatosis and in relatives of patients with alcoholic cirrhosis and haemochromatosis. A comparative study of 27 families. QJ Med 1965;34:427-442
43. Beutler E, Felitti V, Koziol JA, et al. Penetrance of 845G → A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002;359:211-218
44. LeSage GD, Baldus WP, Fairbanks VF, et al. Hemochromatosis: genetic or alcohol-induced? Gastroenterology 1983; 84:1471-1477
45. Cederbaum AI. Oxygen radical generation by microsomes: role of iron and implications for alcohol metabolism and toxicity. Free Radic Biol Med 1989;7:559-567
46. Ekstrom G, Ingelman-Sundberg M. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P450 (P-459 IIE1). Biochem Pharmacol 1989;38:1313-1319
47. Morimoto M, Hagbjork AL, Nanji AA, et al. Role of cytochrome P450 2E1 in alcoholic liver disease pathogenesis. Alcohol 1993;10:459-464
48. Ekstrom G, Cronholm T, Ingelman-Sundberg M. Hydroxyl-radical production of ethanol oxidation by liver microsomes isolated from ethanol treated rats. Biochem J 1986;233:755-761
49. Niemela O, Parkkila S, Britton RS, et al. Hepatic lipid peroxidation in hereditary hemochromatosis and alcoholic liver injury. J Lab Clin Med 1999;133:451-460
50. Bacon B, Tavill A. Role of the liver in normal iron metabolism. Semin Liver Dis 1984;4:181-192
51. Reif DW. Ferritin as a source of iron for oxidative damage. Free Radic Biol Med 1992;12:417-427
52. Shaw S. Lipid peroxidation, iron mobilization and radical generation induced by alcohol. Free Radic Biol Med 1989;7:541-547
53. French SW. The mechanism of organ injury in alcoholics: implications for therapy. Alcohol Alcohol Suppl 1991;1:57-63
54. Sanchez J, Casas M, Rama R. Effect of chronic ethanol administration on iron metabolism in the rat. Eur J Haematol 1988;41:321-325
55. Fairweather-Tait SJ, Southon S, Piper Z. The effect of alcoholic beverages on iron and zinc metabolism in the rat. Br J Nutr 1988;60:209-215
56. Sadrzadeh SMH, Nanji AA, Price PL. The oral iron-chelator, 1,2-dimethyl-3-hydroxypyrid-4-one reduces hepatic-free iron, lipid peroxidation and fat accumulation in chronically ethanol-fed rats. J Pharmacol Exp Ther 1994;269:632-636
57. Hultcrantz R, Bissell DM, Roll FJ. Iron mediates production of a neutrophil chemoattractant by rat hepatocytes metabolizing ethanol. J Clin Invest 1991;87:45-49
58. Tsukamoto H, Towner SJ, Ciafalo LM, et al. Ethanol-induced liver fibrosis in rats fed high fat diet. Hepatology 1986;6:814-822
59. Tsukamoto H, Matsuoka M, French SW, Experimental models of hepatic fibrosis. Semin Liver Dis 1990;10:56-65
60. Tsukamoto H, Horne W, Kamimura S, et al. Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 1995; 96:620-630
61. Adams PC, Chakrabarti S. Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria. Gastroenterology 1998;114:319-323
62. Powell LW, Summers KM, Board PG, et al. Expression of hemochromatosis in homozygous subjects, Implication for early diagnosis and prevention. Gastroenterology 1990;98:1625-1632
63. Adams PC, Frei JV, Bradley C, Lam D. Hepatic iron and iron absorption in hemochromatosis. Clin Invest Med 1990;13:256-258
64. Cotler S, Bronner M, Press D, et al. End-stage liver disease without hemochromatosis associated with elevated hepatic iron index. J Hepatol 1998;29:257-262
65. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene mutation in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408
66. Bacon BR, Powell LW, Adams PC, et al. Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology 1999;116:193-207
67. Bacon BR, Olynyk JK, Brunt EM, et al. HFE genotype in patients with hemochromatosis and other liver diseases. Ann Intern Med 1999;130:953-962
68. Adams PC, Agnew S. Alcoholism in hereditary hemochromatosis revisited: prevalence and clinical consequences among homozygous siblings. Hepatology 1996;23:724-727
69. Fletcher L, Dixon J, Purdie D, et al. Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. Gastroenterology 2002;122:281-289
70. Ioannou GN. The effect of alcohol consumption on the prevalence of iron overload, iron deficiency, and iron deficiency anemia. Gastroenterology 2004;126:1293-1301
71. Regoeczi E, Chindemi PA, Debanne MT. Transferrin glycans: a possible link between alcoholism and alcoholic siderosis. Alcohol Clin Exp Res 1984;8:287-292
72. Beguin Y, Bergamschi G, Huebers H, Finch CA. The behavior of asialotranferrin-iron in the rat. Am J Hematol 1988;29:204-210
73. 59Fe-labeled transferrin by rat liver and cerebellum. Biochem Pharmacol 1994;47:1835-1841
74. Chapman RW, Morgan MY, Boss AM, Sherlock S. Acute and chronic effects of alcohol on iron absorption. Dig Dis Sci 1983;28:321-327
75. Bonkovsky HL, Banner BF, Lambrecht RW, Rubin RB. Iron in liver diseases other than hemochromatosis. Semin Liver Dis 1996;16:65-82
76. Milman N, Graudal N, Hegnhoj J, et al. Relationships among serum iron status markers, chemical and histochemical liver iron content in 117 patients with alcohol and non-alcohol hepatic disease. Hepatogastroenterology 1994;41:20-24
77. Grace ND, Greenberg MS. Phlebotomy in the treatment of iron overload: a controlled trial (a preliminary report.) Gastroenterology 1971;60:744 (Abst)
78. MacPhail AP, Simon MO, Torrance JD, et al. Changing patterns of dietary iron overload in black South Africans. AmJ Clin Nutr 1979;32:1272-1278
79. Issacson C, Seftel H, Keeley KJ, Bothwell TH. Siderosis in the Bantu. The relationship between iron overload and cirrhosis. J Lab Clin Med 1961;58:845-853
80. Gordeuk VR, Mukabi J, Hasstedt J, et al. Iron overload in Africa: interaction between a gene and dietary iron content. N Engl J Med 1992;326:95-100
81. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994;107:1103-1109
82. George DK, Goldwurm S, MacDonald GA, et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998;114:311-318
83. Bonkovsky HL, Jawaid Q, Tortorelli K, et al. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J Hepatol 1999;31:421-429
84. Rocchi E, Gilbertini P, Cassanelli M, et al. Serum ferritin in the assessment of liver iron overload and iron removal therapy in porphyria cutanea tarda. J Lab Clin Med 1986;107:36-42
85. Rocchi E, Gilbertini P, Cassanelli M, et al. Liver iron overload and desferrioxamine treatment of porphyria cutanea tarda. Dermatologica 1991;182:27-31
86. Edwards CQ, Griffen LM, Goldgar DE, et al. HLA-linked hemochromatosis alleles in sporadic porphyria cutanea tarda. Gastroenterology 1989;97:972-981
87. Roberts AG, Whatley SD, Morgan RR, et al. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997;349:321-323
88. Bonkovsky HL. Iron as a comorbid factor in chronic viral hepatitis. Am J Gastroenterol 2002;97:1-3
89. Tung BY, Emond MJ, Bronner MP, et al. Hepatitis C, iron status, and disease severity: relationship with HFE mutations. Gastroenterology 2003;124:318-326
90. Pietrangelo A. Hemochromatosis gene modifies course of hepatitis C viral infection. Gastroenterology 2003;124:1509-1523